Benjamin Lewin

Benjamin Lewin founded Cell in 1972 at the Massachusetts Institute of Technology, and with unprecedented speed, built a collection of science journals that rival—and many say outperform—heavyweights Nature and Science.

Written byPaula Park
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Canadian researcher Tak Wah Mak enjoys the distinction of codiscovering T-cell receptors. But, when he submitted a paper to the journal Cell, the editors treated him like a postdoc: They asked him to go back to the lab and perform one more experiment on a mouse. "I called back and said, 'Do you know how long it takes me to do this experiment? Two or three years!'" he relates. "It's tough to get things published in Cell. They make you jump over the hoops five times."

Such is the legacy of Benjamin Lewin, who founded Cell in 1972 at the Massachusetts Institute of Technology, and with unprecedented speed, built a collection of science journals that rival--and many say outperform--heavyweights Nature and Science. Vowing to reduce time between submission and publication and to present groundbreaking papers only when the data has been substantiated to his satisfaction, Lewin created a cutting-edge journal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery